ATRAID regulates the action of nitrogen-containing bisphosphonates on bone

Journal: Science Translational Medicine

Published: 2020-05-20

DOI: 10.1126/scitranslmed.aav9166

Affiliations: 30

Authors: 38

Go to article
Institutions Share
Department of Anesthesiology, WUSTL, United States of America (USA) 0.31
Washington University School of Medicine (WUSM), WUSTL, United States of America (USA) 0.12
Massachusetts General Hospital (MGH), United States of America (USA) 0.10
Department of Molecular and Human Genetics, BCM, United States of America (USA) 0.08
Harvard Faculty of Arts and Sciences (FAS), United States of America (USA) 0.05
Shriners Hospitals for Children - St. Louis, United States of America (USA) 0.04
Novartis Institutes for Biomedical Research (NIBR), United States of America (USA) 0.03
Division of Biostatistics, WUSTL, United States of America (USA) 0.03
Mallinckrodt Institute of Radiology (MIR), WUSTL, United States of America (USA) 0.03
NYU Division of Endocrinology, Diabetes and Metabolism, United States of America (USA) 0.03
Stanford School of Medicine, United States of America (USA) 0.03
Hospital for Special Surgery (HSS), United States of America (USA) 0.03
The Rockefeller University, United States of America (USA) 0.03
Stanford Department of Microbiology and Immunology, United States of America (USA) 0.03
Harvard School of Dental Medicine (HSDM), United States of America (USA) 0.02
Howard Hughes Medical Institute (HHMI), United States of America (USA) 0.02
Oncode Institute, Netherlands 0.01
Division of Biochemistry, NKI, Netherlands 0.01
Research Center for Molecular Medicine (CeMM), ÖAW, Austria 0.01
Cancer GenomiCs.nl (CGC.nl), Netherlands 0.01
MIT Whitehead Institute for Biomedical Research, United States of America (USA) 0.01
MIT Department of Biology, United States of America (USA) 0.01
MIT David H. Koch Institute for Integrative Cancer Research, United States of America (USA) 0.01

Return